APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cancer Biopsy Instruments and Kits

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Cancer Biopsy Instruments and Kits Market Outlook and Growth Opportunities 2026

4 July 2026190 pages

Choose your research edition.

Industry ResearchCancer Biopsy Instruments and Kits Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Cancer Biopsy Instruments and Kits Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Cancer Biopsy Instruments and Kits Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cancer Biopsy Instruments and Kits Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Cancer Biopsy Instruments and Kits Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Cancer Biopsy Instruments and Kits market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Cancer Biopsy Instruments and Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cancer Biopsy Instruments and Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cancer Biopsy Instruments and Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Cancer Biopsy Instruments and Kits market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Cancer Biopsy Instruments and Kits market include QIAGEN NV, ANGLE plc, Becton, Dickinson and Company, BIOCEPT, INC., Danaher Corporation, Hologic, Inc., Illumina, Inc., Lucence Diagnostics Pte. Ltd. and Myriad Genetics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Cancer Biopsy Instruments and Kits market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cancer Biopsy Instruments and Kits and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cancer Biopsy Instruments and Kits sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cancer Biopsy Instruments and Kits market size, projected growth trends, production technologies, key applications, and end-use industries.

Cancer Biopsy Instruments and Kits Segment by Company

QIAGEN NV

ANGLE plc

Becton, Dickinson and Company

BIOCEPT, INC.

Danaher Corporation

Hologic, Inc.

Illumina, Inc.

Lucence Diagnostics Pte. Ltd.

Myriad Genetics

Thermo Fisher Scientific, Inc.

Cancer Biopsy Instruments and Kits Segment by Type

Cancer Biopsy Instruments

Cancer Biopsy Kits

Cancer Biopsy Instruments and Kits Segment by Application

Breast Cancer

Colorectal Cancer

Cervical Cancer

Lung Cancer

Others

Cancer Biopsy Instruments and Kits Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Cancer Biopsy Instruments and Kits status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Cancer Biopsy Instruments and Kits market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Cancer Biopsy Instruments and Kits significant trends, drivers, influence factors in global and regions.

6. To analyze Cancer Biopsy Instruments and Kits competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cancer Biopsy Instruments and Kits market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cancer Biopsy Instruments and Kits and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cancer Biopsy Instruments and Kits.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cancer Biopsy Instruments and Kits market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cancer Biopsy Instruments and Kits industry.

Chapter 3: Detailed analysis of Cancer Biopsy Instruments and Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Cancer Biopsy Instruments and Kits in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Cancer Biopsy Instruments and Kits in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Cancer Biopsy Instruments and Kits Industry Trends Table 2. Cancer Biopsy Instruments and Kits Industry Drivers Table 3. Cancer Biopsy Instruments and Kits Industry Opportunities and Challenges Table 4. Cancer Biopsy Instruments and Kits Industry Restraints Table 5. Global Cancer Biopsy Instruments and Kits Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Cancer Biopsy Instruments and Kits Revenue Share by Company (2021-2026) Table 7. Global Cancer Biopsy Instruments and Kits Sales Volume by Company (k units) & (2021-2026) Table 8. Global Cancer Biopsy Instruments and Kits Sales Volume Share by Company (2021-2026) Table 9. Global Cancer Biopsy Instruments and Kits Average Price (USD/unit) of Company (2021-2026) Table 10. Global Cancer Biopsy Instruments and Kits Company Ranking, (2024-2026) & (USD Million) Table 11. Global Cancer Biopsy Instruments and Kits Key Company Manufacturing Base & Headquarters Table 12. Global Cancer Biopsy Instruments and Kits Company, Product Type & Application Table 13. Global Cancer Biopsy Instruments and Kits Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Cancer Biopsy Instruments and Kits by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Cancer Biopsy Instruments Table 18. Significant Companies of Cancer Biopsy Kits Table 19. Global Cancer Biopsy Instruments and Kits Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Cancer Biopsy Instruments and Kits Sales Volume by Type (2021-2026) & (k units) Table 21. Global Cancer Biopsy Instruments and Kits Sales Volume by Type (2027-2032) & (k units) Table 22. Global Cancer Biopsy Instruments and Kits Sales Volume Share by Type (2021-2026) Table 23. Global Cancer Biopsy Instruments and Kits Sales Volume Share by Type (2027-2032) Table 24. Global Cancer Biopsy Instruments and Kits Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Cancer Biopsy Instruments and Kits Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Cancer Biopsy Instruments and Kits Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Cancer Biopsy Instruments and Kits Sales Value Share by Type (2021-2026) Table 28. Global Cancer Biopsy Instruments and Kits Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Breast Cancer Table 30. Significant Companies of Colorectal Cancer Table 31. Significant Companies of Cervical Cancer Table 32. Significant Companies of Lung Cancer Table 33. Significant Companies of Others Table 34. Global Cancer Biopsy Instruments and Kits Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Cancer Biopsy Instruments and Kits Sales Volume by Application (2021-2026) & (k units) Table 36. Global Cancer Biopsy Instruments and Kits Sales Volume by Application (2027-2032) & (k units) Table 37. Global Cancer Biopsy Instruments and Kits Sales Volume Share by Application (2021-2026) Table 38. Global Cancer Biopsy Instruments and Kits Sales Volume Share by Application (2027-2032) Table 39. Global Cancer Biopsy Instruments and Kits Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Cancer Biopsy Instruments and Kits Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Cancer Biopsy Instruments and Kits Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Cancer Biopsy Instruments and Kits Sales Value Share by Application (2021-2026) Table 43. Global Cancer Biopsy Instruments and Kits Sales Value Share by Application (2027-2032) Table 44. Global Cancer Biopsy Instruments and Kits Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Cancer Biopsy Instruments and Kits Sales by Region (2021-2026) & (k units) Table 46. Global Cancer Biopsy Instruments and Kits Sales Market Share by Region (2021-2026) Table 47. Global Cancer Biopsy Instruments and Kits Sales by Region (2027-2032) & (k units) Table 48. Global Cancer Biopsy Instruments and Kits Sales Market Share by Region (2027-2032) Table 49. Global Cancer Biopsy Instruments and Kits Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Cancer Biopsy Instruments and Kits Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Cancer Biopsy Instruments and Kits Sales Value Share by Region (2021-2026) Table 52. Global Cancer Biopsy Instruments and Kits Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Cancer Biopsy Instruments and Kits Sales Value Share by Region (2027-2032) Table 54. Global Cancer Biopsy Instruments and Kits Market Average Price (USD/unit) by Region (2021-2026) Table 55. Global Cancer Biopsy Instruments and Kits Market Average Price (USD/unit) by Region (2027-2032) Table 56. Global Cancer Biopsy Instruments and Kits Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Global Cancer Biopsy Instruments and Kits Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Cancer Biopsy Instruments and Kits Sales by Country (2021-2026) & (k units) Table 59. Global Cancer Biopsy Instruments and Kits Sales Market Share by Country (2021-2026) Table 60. Global Cancer Biopsy Instruments and Kits Sales by Country (2027-2032) & (k units) Table 61. Global Cancer Biopsy Instruments and Kits Sales Market Share by Country (2027-2032) Table 62. Global Cancer Biopsy Instruments and Kits Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Cancer Biopsy Instruments and Kits Sales Value Market Share by Country (2021-2026) Table 64. Global Cancer Biopsy Instruments and Kits Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Cancer Biopsy Instruments and Kits Sales Value Market Share by Country (2027-2032) Table 66. QIAGEN NV Company Information Table 67. QIAGEN NV Business Overview Table 68. QIAGEN NV Cancer Biopsy Instruments and Kits Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 69. QIAGEN NV Cancer Biopsy Instruments and Kits Product Portfolio Table 70. QIAGEN NV Recent Development Table 71. ANGLE plc Company Information Table 72. ANGLE plc Business Overview Table 73. ANGLE plc Cancer Biopsy Instruments and Kits Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 74. ANGLE plc Cancer Biopsy Instruments and Kits Product Portfolio Table 75. ANGLE plc Recent Development Table 76. Becton, Dickinson and Company Company Information Table 77. Becton, Dickinson and Company Business Overview Table 78. Becton, Dickinson and Company Cancer Biopsy Instruments and Kits Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 79. Becton, Dickinson and Company Cancer Biopsy Instruments and Kits Product Portfolio Table 80. Becton, Dickinson and Company Recent Development Table 81. BIOCEPT, INC. Company Information Table 82. BIOCEPT, INC. Business Overview Table 83. BIOCEPT, INC. Cancer Biopsy Instruments and Kits Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 84. BIOCEPT, INC. Cancer Biopsy Instruments and Kits Product Portfolio Table 85. BIOCEPT, INC. Recent Development Table 86. Danaher Corporation Company Information Table 87. Danaher Corporation Business Overview Table 88. Danaher Corporation Cancer Biopsy Instruments and Kits Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Danaher Corporation Cancer Biopsy Instruments and Kits Product Portfolio Table 90. Danaher Corporation Recent Development Table 91. Hologic, Inc. Company Information Table 92. Hologic, Inc. Business Overview Table 93. Hologic, Inc. Cancer Biopsy Instruments and Kits Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Hologic, Inc. Cancer Biopsy Instruments and Kits Product Portfolio Table 95. Hologic, Inc. Recent Development Table 96. Illumina, Inc. Company Information Table 97. Illumina, Inc. Business Overview Table 98. Illumina, Inc. Cancer Biopsy Instruments and Kits Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Illumina, Inc. Cancer Biopsy Instruments and Kits Product Portfolio Table 100. Illumina, Inc. Recent Development Table 101. Lucence Diagnostics Pte. Ltd. Company Information Table 102. Lucence Diagnostics Pte. Ltd. Business Overview Table 103. Lucence Diagnostics Pte. Ltd. Cancer Biopsy Instruments and Kits Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Lucence Diagnostics Pte. Ltd. Cancer Biopsy Instruments and Kits Product Portfolio Table 105. Lucence Diagnostics Pte. Ltd. Recent Development Table 106. Myriad Genetics Company Information Table 107. Myriad Genetics Business Overview Table 108. Myriad Genetics Cancer Biopsy Instruments and Kits Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Myriad Genetics Cancer Biopsy Instruments and Kits Product Portfolio Table 110. Myriad Genetics Recent Development Table 111. Thermo Fisher Scientific, Inc. Company Information Table 112. Thermo Fisher Scientific, Inc. Business Overview Table 113. Thermo Fisher Scientific, Inc. Cancer Biopsy Instruments and Kits Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Thermo Fisher Scientific, Inc. Cancer Biopsy Instruments and Kits Product Portfolio Table 115. Thermo Fisher Scientific, Inc. Recent Development Table 116. Key Raw Materials Table 117. Raw Materials Key Suppliers Table 118. Cancer Biopsy Instruments and Kits Distributors List Table 119. Cancer Biopsy Instruments and Kits Customers List Table 120. Research Programs/Design for This Report Table 121. Authors List of This Report Table 122. Secondary Sources Table 123. Primary Sources List of Figures Figure 1. Cancer Biopsy Instruments and Kits Product Image Figure 2. Global Cancer Biopsy Instruments and Kits Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cancer Biopsy Instruments and Kits Sales Value (2021-2032) & (US$ Million) Figure 4. Global Cancer Biopsy Instruments and Kits Sales (2021-2032) & (k units) Figure 5. Global Cancer Biopsy Instruments and Kits Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Cancer Biopsy Instruments and Kits Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Cancer Biopsy Instruments Image Figure 10. Cancer Biopsy Kits Image Figure 11. Global Cancer Biopsy Instruments and Kits Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Cancer Biopsy Instruments and Kits Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Cancer Biopsy Instruments and Kits Sales Volume Share by Type (2021-2032) Figure 14. Global Cancer Biopsy Instruments and Kits Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Cancer Biopsy Instruments and Kits Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Cancer Biopsy Instruments and Kits Sales Value Share by Type (2021-2032) Figure 17. Breast Cancer Image Figure 18. Colorectal Cancer Image Figure 19. Cervical Cancer Image Figure 20. Lung Cancer Image Figure 21. Others Image Figure 22. Global Cancer Biopsy Instruments and Kits Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Cancer Biopsy Instruments and Kits Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Cancer Biopsy Instruments and Kits Sales Volume Share by Application (2021-2032) Figure 25. Global Cancer Biopsy Instruments and Kits Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Cancer Biopsy Instruments and Kits Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Cancer Biopsy Instruments and Kits Sales Value Share by Application (2021-2032) Figure 28. Global Cancer Biopsy Instruments and Kits Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 29. Global Cancer Biopsy Instruments and Kits Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Cancer Biopsy Instruments and Kits Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Cancer Biopsy Instruments and Kits Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Cancer Biopsy Instruments and Kits Sales Value (2021-2032) & (US$ Million) Figure 33. North America Cancer Biopsy Instruments and Kits Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Cancer Biopsy Instruments and Kits Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Cancer Biopsy Instruments and Kits Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Cancer Biopsy Instruments and Kits Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Cancer Biopsy Instruments and Kits Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Cancer Biopsy Instruments and Kits Sales Value (2021-2032) & (US$ Million) Figure 39. South America Cancer Biopsy Instruments and Kits Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Cancer Biopsy Instruments and Kits Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Cancer Biopsy Instruments and Kits Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Cancer Biopsy Instruments and Kits Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Cancer Biopsy Instruments and Kits Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Cancer Biopsy Instruments
  • Cancer Biopsy Kits
Applications
  • Breast Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Lung Cancer
  • Others
Companies covered
  • QIAGEN NV
  • ANGLE plc
  • Becton, Dickinson and Company
  • BIOCEPT, INC.
  • Danaher Corporation
  • Hologic, Inc.
  • Illumina, Inc.
  • Lucence Diagnostics Pte. Ltd.
  • Myriad Genetics
  • Thermo Fisher Scientific, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cancer Biopsy Instruments and Kits Sales Value (2021-2032)
  4. 1.2.2 Global Cancer Biopsy Instruments and Kits Sales Volume (2021-2032)
  5. 1.2.3 Global Cancer Biopsy Instruments and Kits Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Cancer Biopsy Instruments and Kits Market Dynamics
  1. 2.1 Cancer Biopsy Instruments and Kits Industry Trends
  2. 2.2 Cancer Biopsy Instruments and Kits Industry Drivers
  3. 2.3 Cancer Biopsy Instruments and Kits Industry Opportunities and Challenges
  4. 2.4 Cancer Biopsy Instruments and Kits Industry Restraints
3 Cancer Biopsy Instruments and Kits Market by Company
  1. 3.1 Global Cancer Biopsy Instruments and Kits Company Revenue Ranking in 2025
  2. 3.2 Global Cancer Biopsy Instruments and Kits Revenue by Company (2021-2026)
  3. 3.3 Global Cancer Biopsy Instruments and Kits Sales Volume by Company (2021-2026)
  4. 3.4 Global Cancer Biopsy Instruments and Kits Average Price by Company (2021-2026)
  5. 3.5 Global Cancer Biopsy Instruments and Kits Company Ranking (2024-2026)
  6. 3.6 Global Cancer Biopsy Instruments and Kits Company Manufacturing Base and Headquarters
  7. 3.7 Global Cancer Biopsy Instruments and Kits Company Product Type and Application
  8. 3.8 Global Cancer Biopsy Instruments and Kits Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Cancer Biopsy Instruments and Kits Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Cancer Biopsy Instruments and Kits Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Cancer Biopsy Instruments and Kits Market by Type
  1. 4.1 Cancer Biopsy Instruments and Kits Type Introduction
  2. 4.1.1 Cancer Biopsy Instruments
  3. 4.1.2 Cancer Biopsy Kits
  4. 4.2 Global Cancer Biopsy Instruments and Kits Sales Volume by Type
  5. 4.2.1 Global Cancer Biopsy Instruments and Kits Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Cancer Biopsy Instruments and Kits Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Cancer Biopsy Instruments and Kits Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Cancer Biopsy Instruments and Kits Sales Value by Type
  9. 4.3.1 Global Cancer Biopsy Instruments and Kits Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Cancer Biopsy Instruments and Kits Sales Value by Type (2021-2032)
  11. 4.3.3 Global Cancer Biopsy Instruments and Kits Sales Value Share by Type (2021-2032)
5 Cancer Biopsy Instruments and Kits Market by Application
  1. 5.1 Cancer Biopsy Instruments and Kits Application Introduction
  2. 5.1.1 Breast Cancer
  3. 5.1.2 Colorectal Cancer
  4. 5.1.3 Cervical Cancer
  5. 5.1.4 Lung Cancer
  6. 5.1.5 Others
  7. 5.2 Global Cancer Biopsy Instruments and Kits Sales Volume by Application
  8. 5.2.1 Global Cancer Biopsy Instruments and Kits Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Cancer Biopsy Instruments and Kits Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Cancer Biopsy Instruments and Kits Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Cancer Biopsy Instruments and Kits Sales Value by Application
  12. 5.3.1 Global Cancer Biopsy Instruments and Kits Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Cancer Biopsy Instruments and Kits Sales Value by Application (2021-2032)
  14. 5.3.3 Global Cancer Biopsy Instruments and Kits Sales Value Share by Application (2021-2032)
6 Cancer Biopsy Instruments and Kits Regional Sales and Value Analysis
  1. 6.1 Global Cancer Biopsy Instruments and Kits Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cancer Biopsy Instruments and Kits Sales by Region (2021-2032)
  3. 6.2.1 Global Cancer Biopsy Instruments and Kits Sales by Region: 2021-2026
  4. 6.2.2 Global Cancer Biopsy Instruments and Kits Sales by Region (2027-2032)
  5. 6.3 Global Cancer Biopsy Instruments and Kits Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Cancer Biopsy Instruments and Kits Sales Value by Region (2021-2032)
  7. 6.4.1 Global Cancer Biopsy Instruments and Kits Sales Value by Region: 2021-2026
  8. 6.4.2 Global Cancer Biopsy Instruments and Kits Sales Value by Region (2027-2032)
  9. 6.5 Global Cancer Biopsy Instruments and Kits Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Cancer Biopsy Instruments and Kits Sales Value (2021-2032)
  12. 6.6.2 North America Cancer Biopsy Instruments and Kits Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Cancer Biopsy Instruments and Kits Sales Value (2021-2032)
  15. 6.7.2 Europe Cancer Biopsy Instruments and Kits Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Cancer Biopsy Instruments and Kits Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Cancer Biopsy Instruments and Kits Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Cancer Biopsy Instruments and Kits Sales Value (2021-2032)
  21. 6.9.2 South America Cancer Biopsy Instruments and Kits Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Cancer Biopsy Instruments and Kits Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Cancer Biopsy Instruments and Kits Sales Value Share by Country, 2025 VS 2032
7 Cancer Biopsy Instruments and Kits Country-level Sales and Value Analysis
  1. 7.1 Global Cancer Biopsy Instruments and Kits Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cancer Biopsy Instruments and Kits Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Cancer Biopsy Instruments and Kits Sales by Country (2021-2032)
  4. 7.3.1 Global Cancer Biopsy Instruments and Kits Sales by Country (2021-2026)
  5. 7.3.2 Global Cancer Biopsy Instruments and Kits Sales by Country (2027-2032)
  6. 7.4 Global Cancer Biopsy Instruments and Kits Sales Value by Country (2021-2032)
  7. 7.4.1 Global Cancer Biopsy Instruments and Kits Sales Value by Country (2021-2026)
  8. 7.4.2 Global Cancer Biopsy Instruments and Kits Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Cancer Biopsy Instruments and Kits Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Cancer Biopsy Instruments and Kits Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Cancer Biopsy Instruments and Kits Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 QIAGEN NV
  2. 8.1.1 QIAGEN NV Company Information
  3. 8.1.2 QIAGEN NV Business Overview
  4. 8.1.3 QIAGEN NV Cancer Biopsy Instruments and Kits Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 QIAGEN NV Cancer Biopsy Instruments and Kits Product Portfolio
  6. 8.1.5 QIAGEN NV Recent Developments
  7. 8.2 ANGLE plc
  8. 8.2.1 ANGLE plc Company Information
  9. 8.2.2 ANGLE plc Business Overview
  10. 8.2.3 ANGLE plc Cancer Biopsy Instruments and Kits Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 ANGLE plc Cancer Biopsy Instruments and Kits Product Portfolio
  12. 8.2.5 ANGLE plc Recent Developments
  13. 8.3 Becton, Dickinson and Company
  14. 8.3.1 Becton, Dickinson and Company Company Information
  15. 8.3.2 Becton, Dickinson and Company Business Overview
  16. 8.3.3 Becton, Dickinson and Company Cancer Biopsy Instruments and Kits Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Becton, Dickinson and Company Cancer Biopsy Instruments and Kits Product Portfolio
  18. 8.3.5 Becton, Dickinson and Company Recent Developments
  19. 8.4 BIOCEPT, INC.
  20. 8.4.1 BIOCEPT, INC. Company Information
  21. 8.4.2 BIOCEPT, INC. Business Overview
  22. 8.4.3 BIOCEPT, INC. Cancer Biopsy Instruments and Kits Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 BIOCEPT, INC. Cancer Biopsy Instruments and Kits Product Portfolio
  24. 8.4.5 BIOCEPT, INC. Recent Developments
  25. 8.5 Danaher Corporation
  26. 8.5.1 Danaher Corporation Company Information
  27. 8.5.2 Danaher Corporation Business Overview
  28. 8.5.3 Danaher Corporation Cancer Biopsy Instruments and Kits Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Danaher Corporation Cancer Biopsy Instruments and Kits Product Portfolio
  30. 8.5.5 Danaher Corporation Recent Developments
  31. 8.6 Hologic, Inc.
  32. 8.6.1 Hologic, Inc. Company Information
  33. 8.6.2 Hologic, Inc. Business Overview
  34. 8.6.3 Hologic, Inc. Cancer Biopsy Instruments and Kits Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Hologic, Inc. Cancer Biopsy Instruments and Kits Product Portfolio
  36. 8.6.5 Hologic, Inc. Recent Developments
  37. 8.7 Illumina, Inc.
  38. 8.7.1 Illumina, Inc. Company Information
  39. 8.7.2 Illumina, Inc. Business Overview
  40. 8.7.3 Illumina, Inc. Cancer Biopsy Instruments and Kits Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Illumina, Inc. Cancer Biopsy Instruments and Kits Product Portfolio
  42. 8.7.5 Illumina, Inc. Recent Developments
  43. 8.8 Lucence Diagnostics Pte. Ltd.
  44. 8.8.1 Lucence Diagnostics Pte. Ltd. Company Information
  45. 8.8.2 Lucence Diagnostics Pte. Ltd. Business Overview
  46. 8.8.3 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Instruments and Kits Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Instruments and Kits Product Portfolio
  48. 8.8.5 Lucence Diagnostics Pte. Ltd. Recent Developments
  49. 8.9 Myriad Genetics
  50. 8.9.1 Myriad Genetics Company Information
  51. 8.9.2 Myriad Genetics Business Overview
  52. 8.9.3 Myriad Genetics Cancer Biopsy Instruments and Kits Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Myriad Genetics Cancer Biopsy Instruments and Kits Product Portfolio
  54. 8.9.5 Myriad Genetics Recent Developments
  55. 8.10 Thermo Fisher Scientific, Inc.
  56. 8.10.1 Thermo Fisher Scientific, Inc. Company Information
  57. 8.10.2 Thermo Fisher Scientific, Inc. Business Overview
  58. 8.10.3 Thermo Fisher Scientific, Inc. Cancer Biopsy Instruments and Kits Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Thermo Fisher Scientific, Inc. Cancer Biopsy Instruments and Kits Product Portfolio
  60. 8.10.5 Thermo Fisher Scientific, Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cancer Biopsy Instruments and Kits Value Chain Analysis
  2. 9.1.1 Cancer Biopsy Instruments and Kits Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cancer Biopsy Instruments and Kits Sales Mode & Process
  6. 9.2 Cancer Biopsy Instruments and Kits Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cancer Biopsy Instruments and Kits Distributors
  9. 9.2.3 Cancer Biopsy Instruments and Kits Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst